Related Experiment Videos
Mutant p53 proteins bind DNA abnormally in vitro.
S E Kern1, K W Kinzler, S J Baker
1Oncology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231.
Oncogene
|January 1, 1991
Summary
Mutant p53 proteins from tumors bind DNA less effectively than normal p53. These mutations, found in key gene regions, impair p53
Area of Science:
- Molecular Biology
- Cancer Genetics
- Protein Biochemistry
Background:
- The p53 gene encodes a DNA-binding phosphoprotein crucial for cellular regulation.
- Mutations in the p53 gene are prevalent in various human tumors.
- The functional impact of p53 mutations on its intrinsic properties, particularly DNA-binding, remains largely uncharacterized.
Purpose of the Study:
- To investigate the effects of diverse p53 mutations on the DNA-binding capabilities of the p53 protein.
- To correlate mutation location within the p53 gene with alterations in DNA-binding affinity.
Main Methods:
- Production of 15 distinct mutant p53 gene products from human tumors and mouse transformants.
- Assessment of DNA-binding affinity of mutant p53 proteins to calf thymus DNA using biochemical assays.
- Analysis of protein phosphorylation status in a reticulocyte lysate system.
Main Results:
- All 15 tested mutant p53 proteins exhibited weaker binding to DNA compared to wild-type p53.
- A subset of mutant p53 proteins showed reduced phosphorylation, but this did not fully explain the diminished DNA-binding.
- Mutations were located across multiple p53 gene regions, including evolutionarily conserved 'hot spots'.
Conclusions:
- p53 mutations commonly found in tumors significantly impair the protein's ability to bind DNA.
- These findings suggest convergent mechanisms by which diverse p53 mutations compromise its normal function.
- Understanding these mechanisms is critical for comprehending tumor development and exploring therapeutic strategies.